Please Wait...

Margaret Ziola

Main profile

Margaret Ziola, MD
Medical Director, Cardiology and Neurovascular

In her position as Medical Director, Cardiology and Neurovascular at Synarc, she is responsible for the scientific oversight of all cardiovascular projects including coordination and collaboration with key opinion leaders and expert readers as well as our Sponsor's scientific counterparts. Dr. Ziola participates in clinical trial protocol design and data interpretation and regulatory strategy planning. She oversees the quality of Synarc's cardiology and neurovascular reading services and explores new applications of imaging to clinical trial research.

Dr. Ziola has more than twenty years of cardiovascular experience in support of pharmaceutical research and development programs. Her expertise includes clinical analysis, interpretation, and reporting of cardiac safety data for over 100 clinical trials in various therapeutic indications, including cardiovascular, infectious disease, oncology, CNS, gastroenterology, and endocrinology.

Dr. Ziola holds her medical degree from the Nicolaus Copernicus Jagiellonian University Medical School in Krakow, Poland. She has participated in expert meetings, given invited lectures and co-authored several scientific articles.

Prior to joining Synarc, Dr. Ziola worked at ARYx Therapeutics leading global cardiovascular clinical trials design, conduct and monitoring. Earlier in her career, she served as Director of Cardiovascular Clinical Services position at Gentiae Clinical Research, a cardiovascular core lab she helped establish, supporting central reading of cardiac imaging and electrocardiography. Prior to that she was affiliated with the groundbreaking Ischemia Research and Education Foundation.

Blogs

Part 1 of 2 It was both a great learning experience and fun to participate in another user conference, BioClinica's fifth and my third since joining the company in 2013. We spent quality time with both long-time collaborators and first-time partners.

LEARN MORE OR SPEAK WITH OUR EXPERTS

CONTACT US
Leader in Clinical Trial
Management Solutions

Bioclinica is organized into three business segments so that we can provide expert service and multifaceted technologies. Our Medical Imaging & Biomarkers segment includes an Imaging Core Lab, a Cardiovascular Safety division, and a Molecular Marker Laboratory. Our eHealth segment comprises eClinical Solutions, Randomization & Trial Supply Management, Safety & Regulatory Solutions, and Financial Lifecycle Solutions. Under the Global Clinical Research segment, we offer a network of research sites, patient recruitment, and a Post-Approval Research division.

Great advice from our Dir. Cardiovascular Imaging on quality imaging acquisitions & assessments in clin trials. https://t.co/OVH7pZ3SL0
bioclinica (42 minutes ago)
Almost here! #PCTrials Pre-arrange a meeting w @bioclinica Drop by & s/w David Kiger & Mike Lange. Mike will give a… https://t.co/8ymd2Q9KcJ
bioclinica (52 minutes ago)
Almost here! #PCTrials Pre-arrange a meeting w @bioclinica Drop by & s/w David Kiger & Mike Lange. Mike will giv… https://t.co/MpxTDV1T1L
bioclinica (54 minutes ago)
RT @bioclinica: Keeping to timelines in #clinicaltrials is key but can be hard to achieve. Join Bioclinica's Justin Hunt a webinar Nov. 2…
bioclinica (57 minutes ago)
RT @Xtalks: Removing Risk from #ClinicalTrial Management System (CTMS) Implementations @bioclinica https://t.co/EfuSVMSL13
bioclinica (7 hours ago)
Our Research Dev. Director Marieke Cajal in a poster presentation at #CNS Summit showed, "How to Scale up Recruitme… https://t.co/ySQpGIjvt9
bioclinica (7 hours ago)

Latest Blogs:

Removing Risk from Clinical Trial Management System (CTMS) Implementations
Collaboration Between Clinical Operations and the Logistics and Supply Chain Teams is Key to Trial Success
The Value of Protocol Review
CTMS and RBM: Hot Topics at OCT Nordics in Copenhagen
Congressman Meehan and Bioclinica CEO John Hubbard at recent visit to Bioclinica's Audubon offices